Sign In
Buy LFMD
$3.50
-0.140 (-3.85%)
At Close: Jul 31, 2026
Critical Survey: Ryman Healthcare (OTCMKTS:RYHTY) vs. LifeMD (NASDAQ:LFMD)
01:59am, Thursday, 30'th Jul 2026
LifeMD (NASDAQ: LFMD - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses b
LifeMD to Report Second Quarter 2026 Financial Results on August 5
04:05pm, Friday, 24'th Jul 2026
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six mont
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
08:00am, Tuesday, 23'rd Jun 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to h
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, l
LifeMD Appoints Umesh Sripad as Chief Technology Officer
08:05am, Monday, 01'st Jun 2026
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two
LifeMD to Participate in Upcoming Investor Conferences
08:00am, Friday, 15'th May 2026
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming inve
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
11:01pm, Wednesday, 06'th May 2026
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
07:35pm, Wednesday, 06'th May 2026
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.01 per share a year ago.
LifeMD Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance. Gross margin increased approximately 420 basis point
LifeMD to Report First Quarter 2026 Financial Results on May 6
08:00am, Monday, 27'th Apr 2026
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
09:01am, Tuesday, 21'st Apr 2026
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
08:15am, Friday, 10'th Apr 2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® LifeMD expands its weight
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
08:45am, Tuesday, 31'st Mar 2026
Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk Delivering up to $1,200 in annual patient savings on branded GLP-1 therap
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
04:05pm, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of “Moderate Buy” by Brokerages
02:24am, Tuesday, 17'th Mar 2026
Shares of LifeMD, Inc. (NASDAQ: LFMD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine analysts that are covering the company, MarketBeat.com reports. One anal
